Other headlinesSectra lands multi-site contractMR/XR suites clear FDA
ProSolv alliance boosts outcomes reporting
Fujifilm’s ProSolv CardioVascular now provides the means to collect cardiology data for outcomes reporting, thanks to a partnership with Cedaron Medical. Integration of the cardiovascular PACS Synapse ProSolv with Cedaron’s CardiacCare solution provides a single point of access for all image management, clinical reporting, and outcomes reporting for diagnostic and interventional cardiac procedures, according to ProSolv. The unified system collects procedural information and automatically populates registry templates, such as the American College of Cardiology (ACC) National Cardiovascular Data, CathPCI, ICD, CARE and ACTION registries.
Sectra lands multi-site contract
Swedish PACS/IT vendor Sectra will supply and operate RIS/PACS for a dozen Norwegian radiology clinics under a six-year agreement signed with Curato, the owner of the clinics. The deal, valued at SEK 100 million ($14.6 million), also calls for the two companies to conduct joint research projects focused on imaging improving diagnostics.
MR/XR suites clear FDA
The FDA has cleared Manitoba-based IMRIS to market a combination MR and x-ray angiography suite that allows multi-modality imaging of neurovascular and cardiac patients before, during, and after interventions. IMRISNV and IMRIScardio are the first such suites in the world, according to the Canadian company. IMRISNV includes an integrated wide bore 3T MRI scanner and bi-plane angiography system. IMRIScardio comes equipped with a wide-bore 1.5T MRI scanner and a single-plane or bi-plane angiography system. IMRIS received CE Mark regulatory approval in Europe for IMRISNV and IMRIScardio earlier this year. A marketing application is pending with Health Canada.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.